Hydroxyurea information for children and parents
Intended for healthcare professionals
Clinical Previous     Next

Hydroxyurea information for children and parents

Suzi Crawford Specialist Nurse Haemoglobinopathy, Birmingham Sickle Cell and Thalassaemia Service, Ladywood Community and Health Centre, Birmingham

Patients and parents found combined information and review booklets helpful for understanding complex drug treatment, as Suzi Crawford explains

Provision of accurate, understandable information has always been, and will continue to be, a vital element in patient care. Information about medication and other treatments is important because it enables the individual to give informed consent: to accept or decline any treatment being offered. When staff at the Birmingham Children’s Hospital began offering hydroxyurea treatment to selected children and young people with heamoglobinopathies, it was decided that a booklet should be developed which would incorporate information, consent forms and review information.

Nursing Children and Young People. 15, 2, 40-41. doi: 10.7748/paed.15.2.40.s21

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more